Interact to see
Advertisement
Advertisement
USPRX vs VITSX
USPRX vs VITSX Comparison
Open Charts USPRX vs VITSX
USPRX vs VITSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
USPRX vs. VITSX commentary
Aug 03, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USPRX is a StrongBuy and VITSX is a Buy.
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 2.3T vs. USPRX (15.3B). VITSX pays higher dividends than USPRX: VITSX (1.06) vs USPRX (0.88). USPRX was incepted earlier than VITSX: USPRX (24 years) vs VITSX (29 years). USPRX (0.19) is less costly to investors than VITSX (0.03). VITSX is a more actively managed with annual turnover of: 3.00 vs. USPRX (2.00). USPRX has a lower initial minimum investment than VITSX: USPRX (100000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 18.52 vs. USPRX (15.52). VITSX (63.15) and USPRX (60.73) have equivalent 5 years return.
| USPRX | VITSX | USPRX / VITSX | |
| Total Expense Ratio | 0.15 | 0.03 | 500% |
| Annual Report Gross Expense Ratio | 0.19 | 0.03 | 633% |
| Fund Existence | 24 years | 29 years | - |
| Gain YTD | 10.134 | 9.881 | 103% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 5000000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 15.3B | 2.3T | 1% |
| Annual Yield % from dividends | 0.88 | 1.06 | 83% |
| Returns for 1 year | 15.52 | 18.52 | 84% |
| Returns for 3 years | 60.05 | 62.19 | 97% |
| Returns for 5 years | 60.73 | 63.15 | 96% |
| Returns for 10 years | 226.25 | 246.79 | 92% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DQICX | 39.59 | 0.21 | +0.53% |
| BNY Mellon Equity Income Fund C | |||
| CLREX | 57.72 | 0.27 | +0.47% |
| Columbia Balanced Inst2 | |||
| DBORX | 25.45 | 0.10 | +0.39% |
| BNY Mellon Balanced Opportunity I | |||
| DRRYX | 17.75 | 0.02 | +0.11% |
| BNY Mellon Global Real Return - Y | |||
| LYFIX | 17.94 | -0.50 | -2.71% |
| AlphaCentric Life Sciences & Hlthcare I | |||